Buscar
01/02/2026
Real-World Effectiveness and Safety of Tildrakizumab for Plaque Psoriasis: A 3-Year International Multicenter Retrospective Study
Torres, T, Sood, S, Yilmaz, O, Vender, RB, Prajapati, VH, Puig, L, Megna, M, Marzano, AV, Gisondi, P, Carrascosa, JM, Dauden, E, Llamas-Velasco, M, Balato, A, Leal, BG, Prignano, F, Bellinato, F, Silvi, G, Di Brizzi, EV, Potestio, L, Carrera, CG, López-Ferrer, A, Del-Alcazar, E, Mufti, A, Maul, LV, Piaserico, S, Maul, JT, Yeung, JS. Real-World Effectiveness and Safety of Tildrakizumab for Plaque Psoriasis: A 3-Year International Multicenter Retrospective Study. Dermatology and Therapy. 2026; 16(2)DOI:10.1007/s13555-026-01653-w. PMID:41575604. IF:4.200(Q1/1D).
01/02/2026
Efficacy and Safety of Risankizumab in Psoriatic Patients With a History of Malignancy: Real-World Evidence From a Multicentre Spanish Study
Díaz, JM, Alarcon, SS, Romero, IB, Apetrei, LS, Fernández, LG, Ramos, FJM, Alberola, FT, Martínez, MAB, Ruiz, AB, Rodríguez, OB, Ruiz-Villaverde, R, González, MC, Farrés, MF, Puchades, AM, Tapial, JM, Rull, EV, Montalvo, SM. Efficacy and Safety of Risankizumab in Psoriatic Patients With a History of Malignancy: Real-World Evidence From a Multicentre Spanish Study. AUSTRALASIAN JOURNAL OF DERMATOLOGY. 2026; 67(1)DOI:10.1111/ajd.70012. PMID:41347368. IF:1.800(Q3/6D).
01/02/2026
Management of Obesity in Psoriasis Consultations
Nicolau, J, López-Ferrer, A, de la Cueva, P. Management of Obesity in Psoriasis Consultations. Dermatology and Therapy. 2026; 16(2)DOI:10.1007/s13555-026-01664-7. PMID:41627722. IF:4.200(Q1/1D).
01/02/2026
Intrahepatic Versus Extrahepatic Biliary Tree Cysts: Outcomes after Surgical Resection in a Multicentric Study
Ferrari, C, D'Ambrosio, GM, Martin, B, Romera, AG, Molina, V, Griseri, G, Moral, A, Sánchez-Cabús, S. Intrahepatic Versus Extrahepatic Biliary Tree Cysts: Outcomes after Surgical Resection in a Multicentric Study. Journal of Laparoendoscopic & Advanced Surgical Techniques. 2026; 36(2)DOI:10.1177/10926429251408365. PMID:41467982. IF:1.100(Q3/7D).